简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-10-16 16:03 Novotech Earns Great Place to Work® Certification in the United States
2024-10-15 09:29 Invisalign® Palatal Expander System by Align Technology Now Available in Hong Kong for Skeletal and Dental Expansion in Growing Patients
2024-10-10 11:28 Kewpie Confirms Improved Ease of Eating Vegetables and Other Foods Through Adding Mayonnaise or Emulsified Dressings
2024-10-10 11:19 Avania Buys Spanish MedTech CRO Anagram to Enhance Its Core CRO Offering in a New European Geography
2024-10-10 11:14 EU Notified Body (BSI Netherlands) and the EMA Grant Approval of the LeukoStrat® CDx FLT3 Mutation Assay for VANFLYTA® Therapy in the EU and EEA
2024-10-09 15:17 JT Group Completes Acquisition of Vector Group Ltd.
2024-10-09 11:14 Novaliq and Laboratoires Théa Announce Partnership and EU Approval for Vevizye® (Ciclosporin 0.1% Eye Drops Solution)
2024-10-09 09:59 Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility
2024-10-09 09:30 CAI Appoints Sheena Dempsey as Chief Executive Officer
2024-10-08 16:16 Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities
2024-10-08 15:57 Cancer Therapy: AOP Health Investigates a New Approach Targeting Cancer Stem Cells
2024-10-08 14:56 Ferring Demonstrates Effectiveness of a Treat-to-Target Approach in Mild-to-Moderate Ulcerative Colitis in First Major Study
2024-10-08 11:51 Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11
2024-09-27 14:49 Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors
2024-09-26 13:50 Medidata Extends Its Commitment to the Patient Experience with the Launch of Patient Payments
2024-09-26 10:35 Fujirebio Submits FDA Regulatory Filing for Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease
2024-09-26 09:52 Merz Aesthetics Announces the Launch of Ultherapy PRIME Platform as the Next Generation of Nonsurgical Skin Lifting Treatments
2024-09-26 09:46 PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products
2024-09-25 16:42 Rigaku Holdings Corporation: Approval of Listing on the Tokyo Stock Exchange Prime Market
2024-09-25 13:25 EADV 2024 Late Breaking News Sessions: New Galderma Data Demonstrating Nemolizumab’s Long-term Efficacy and Safety in Atopic Dermatitis and Durability in Prurigo Nodularis to Be Shared During Three Oral Presentations

Business Wire Weibo

Press Releases

Latest Releases